磁共振新技术对肝纤维化诊断的研究进展

摘要/Abstract

摘要： 肝纤维化是各种慢性肝病的损伤愈合反应, 早期诊治肝纤维化对病情逆转颇为重要, 准确的肝纤维化分期有助于临床制定治疗方案、评估病情预后及防治并发症。近年来, 各种无创性磁共振成像新技术为肝纤维化的临床诊治打开了新视角。本文主要综述近年来磁共振成像新技术对肝纤维化分期的研究进展。

关键词: 肝纤维化, 磁共振成像, 诊断

Abstract: Liver fibrosis is an injured and healing reaction of various chronic liver diseases. Early diagnosis and treatment plays an important role in the halt of the progression.Accurate liver fibrosis staging is helpful for formulation plan of treatment, evaluation of prognosis and prevention and treatment of complications. Recently, there are new perspectives for diagnosis and treatment from multiple new non-invasive magnetic resonance imaging(MRI) techniques. This paper aims to review the recent progress of new MRI techniques for staging liver fibrosis.

Key words: Liver fibrosis, Magnetic resonance imaging, Diagnosis

张豪, 邹立秋. 磁共振新技术对肝纤维化诊断的研究进展[J]. 新发传染病电子杂志, 2019, 4(4): 247-251.

ZHANG Hao, ZOU Li-qiu. Progress of new MRI techniques in diagnosis of liver fibrosis[J]. Electronic Journal of Emerging Infectious Diseases, 2019, 4(4): 247-251.

参考文献

[1] Sandrasegaran K, Territo P, Elkady RM, et al.Does intravoxel incoherent motion reliably stage hepatic fibrosis, steatosis, and inflammation?[J]. Abdom Radiol, 2017, 43(3):600-606.
[2] Hoodeshenas S, Yin M, Venkatesh SK.Magnetic Resonance Elastography of Liver[J]. TopMagn Reson Imaging, 2018, 27(5):319-333.
[3] Yoon JH, Lee JM, Lee KB, et al.Comparison of monoexponential, intravoxel incoherent motion diffusion-weighted imaging and diffusion kurtosis imaging for assessment of hepatic fibrosis[J]. Acta Radiol, 2019, 25(1):1-9.
[4] Mathew RP, Venkatesh SK.Imaging of Hepatic Fibrosis[J]. Current Gastroenterol Rep, 2018, 20(10):1-10.
[5] Castera L, Friedrich-Rust M, Loomba R.Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease[J]. Gastroenterology, 2019, 156(5):1264-1281.
[6] Schwimmer JB, Behling C, Angeles JE, et al.Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease[J]. Hepatology, 2017, 66(5):1474-1485.
[7] Petitclerc L, Sebastiani G, Gilbert G, et al.Liver fibrosis: Review of current imaging and MRI quantification techniques[J]. J Magn Reson Imaging, 2017, 45(5):1276-1295.
[8] Loomba R, Wolfson T, Ang B, et al.Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study[J]. Hepatology, 2014, 60(6):1920-1928.
[9] Wu W, Hoi C, Chen R, et al.Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis[J]. Medicine, 2017, 96(42):e8339.
[10] Morisaka H, Motosugi U, Ichikawa S, et al.Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging[J]. J Magn Reson Imaging, 2017, 47(5):1268-1275.
[11] Chou C, Chen R, Wu W, et al.Prospective Comparison of the Diagnostic Performance of Magnetic Resonance Elastography with Acoustic Radiation Force Impulse Elastography for Pre-operative Staging of Hepatic Fibrosis in Patients with Hepatocellular Carcinoma[J]. Ultrasound Med Biol, 2017, 43(12):2783-2790.
[12] Abe K, Takahashi A, Imaizumi H, et al.Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease[J]. J Gastroen Hepatol, 2018, 33(3):733-740.
[13] Lee DH, Lee JM, Chang W, et al.Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease[J]. Eur Radiol, 2018, 28(8):3513-3521.
[14] Tapper EB, Loomba R.Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD[J]. Nat Rev Gastro Hepat, 2018, 15(5):274-282.
[15] Serai SD, Trout AT, Miethke A, et al.Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis[J]. Pediatr Radiol, 2018, 48(9):1256-1272.
[16] Zhan C, Kannengiesser S, Chandarana H, et al.MR elastography of liver at 3 Tesla: comparison of gradient-recalled echo (GRE) and spin-echo (SE) echo-planar imaging (EPI) sequences and agreement across stiffness measurements[J]. Abdom Radiol, 2019, 44(5):1825-1833.
[17] Calle-Toro JS, Serai SD, Hartung EA, et al.Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease[J]. Abdom Radiol, 2019, 44(3):894-902.
[18] Lu PX, Huang H, Yuan J, et al.Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: a prospective clinical intravoxel incoherent motion MR imaging study[J]. PLoS One, 2014, 9(12):e113846.
[19] Leitao HS, Doblas S, Garteiser P, et al.Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease[J]. Radiology, 2017, 283(1):98-107.
[20] Wáng YXJ, Li YT, Chevallier O, et al.Dependence of intravoxel incoherent motion diffusion MR threshold b-value selection for separating perfusion and diffusion compartments and liver fibrosis diagnostic performance[J]. Acta Radiol, 2018, 60(1):3-12.
[21] 王毅翔. 不用b=0图像的活体组织体素内不相干运动分析:应用在肝脏纤维化评估的一个例子[J]. 新发传染病电子杂志, 2019, 4(1):8-14.
[22] Wáng YXJ, Deng M, Li YT, et al.A Combined Use of Intravoxel Incoherent Motion MRI Parameters Can Differentiate Early-Stage Hepatitis-b Fibrotic Livers from Healthy Livers[J]. SLAS TECHNOL: Translating Life Sciences Innovation, 2018, 23(3):259-268.
[23] Haimerl M, Utpatel K, Verloh N, et al.Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis[J]. Sci Rep, 2017, 7:41429.
[24] Zhou Z, Long L, Qiu W, et al.Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic[J]. Abdom Radiol, 2017, 42(9):2272-2278.
[25] Zhang W, Wang X, Miao Y, et al.Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla[J]. Abdom Radiol, 2018, 43(9):2262-2269.
[26] Kudo M, Gotohda N, Sugimoto M, et al.Evaluation of liver function using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging based on a three-dimensional volumetric analysis system[J]. Hepatol Int, 2018, 12(4):368-376.
[27] Renzulli M, Biselli M, Brocchi S, et al.New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm[J]. Gut, 2018, 67(9):1674-1682.
[28] Jiang H, Zheng T, Duan T, et al.Non-invasive in vivo Imaging Grading of Liver Fibrosis[J]. J Clin Transl Hepatol, 2018, 6(2):1-10.
[29] Wu J, Yu Y, Qu X, et al.Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity[J]. World J Gastroentero, 2018, 24(3):415-423.
[30] Petitclerc L, Gilbert G, Nguyen BN, et al.Liver Fibrosis Quantification by Magnetic Resonance Imaging[J]. Top Magn Reson Imaging, 2017, 26(6):229-241.
[31] Chen W, Chen X, Yang L, et al.Quantitative assessment of liver function with whole-liver T1rho mapping at 3.0 T[J]. Magn Reson Imaging, 2018, 46:75-80.
[32] Sheng RF, Wang HQ, Yang L, et al.Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance[J]. Digest Liver Dis, 2017, 49(7):789-795.
[33] Heye T, Yang S, Bock M, et al.MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis[J]. Eur Radiol, 2012, 22(6):1224-1232.
[34] Luetkens JA, Klein S, Traber F, et al.Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results[J]. Radiology, 2018, 288(3):748-754.
[35] Besa C, Bane O, Jajamovich G, et al.3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function[J]. Magn Reson Imaging, 2015, 33(9):1075-1082.
[36] Labranche R, Gilbert G, Cerny M, et al.Liver Iron Quantification with MR Imaging: A Primer for Radiologists[J]. Radiographics, 2018, 38(2):392-412.
[37] Cai Y, Huang M, Wang X, et al.Quantitative analysis of susceptibility-weighted magnetic resonance imaging in chronic hepatitis in rats[J]. Magn Reson Imaging, 2018, 54:71-76.
[38] Balassy C, Feier D, Peck-Radosavljevic M, et al.Susceptibility-weighted MR imaging in the grading of liver fibrosis: a feasibility study[J]. Radiology, 2014, 270(1):149-158.
[39] Feier D, Balassy C, Bastati N, et al.The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis—a multiparametric approach[J]. Eur Radiol, 2016, 26(2):539-546.